Christopher Seiter
Keine laufenden Positionen mehr
Profil
Christopher Seiter worked as the Chief Financial Officer at Trevi Therapeutics, Inc. from 2018 to 2021.
Prior to that, he held the same position at Millendo Therapeutics, Inc. He also worked as MD & Head-Life Sciences Investment Banking at Bank of America Merrill Lynch (New York).
Seiter completed his undergraduate degree at the University of Rochester.
Ehemalige bekannte Positionen von Christopher Seiter
| Unternehmen | Position | Ende |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Finanzdirektor/CFO | 02.04.2021 |
| Bank of America Merrill Lynch (New York) | Corporate Officer/Principal | - |
| MILLENDO THERAPEUTICS | Finanzdirektor/CFO | - |
Ausbildung von Christopher Seiter
| Rochester Christian University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI. | Health Technology |
| Bank of America Merrill Lynch (New York) |
